BACKGROUND: Hypertriglyceridemia may be associated with important complications. The aim of this study is to estimate the magnitude of association and quality of supporting evidence linking hypertriglyceridemia to cardiovascular events and pancreatitis. METHODS: We conducted a systematic review of multiple electronic bibliographic databases and subsequent meta-analysis using a random effects model. Studies eligible for this review followed patients longitudinally and evaluated quantitatively the association of fasting hypertriglyceridemia with the outcomes of interest. Reviewers working independently and in duplicate reviewed studies and extracted data. RESULTS: 35 studies provided data sufficient for meta-analysis. The quality of these observational studies was moderate to low with fair level of multivariable adjustments and adequate exposure and outcome ascertainment. Fasting hypertriglyceridemia was significantly associated with cardiovascular death (odds ratios (OR) 1.80; 95% confidence interval (CI) 1.31-2.49), cardiovascular events (OR, 1.37; 95% CI, 1.23-1.53), myocardial infarction (OR, 1.31; 95% CI, 1.15-1.49), and pancreatitis (OR, 3.96; 95% CI, 1.27-12.34, in one study only). The association with all-cause mortality was not statistically significant. CONCLUSIONS: The current evidence suggests that fasting hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.Précis: hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.
BACKGROUND:Hypertriglyceridemia may be associated with important complications. The aim of this study is to estimate the magnitude of association and quality of supporting evidence linking hypertriglyceridemia to cardiovascular events and pancreatitis. METHODS: We conducted a systematic review of multiple electronic bibliographic databases and subsequent meta-analysis using a random effects model. Studies eligible for this review followed patients longitudinally and evaluated quantitatively the association of fasting hypertriglyceridemia with the outcomes of interest. Reviewers working independently and in duplicate reviewed studies and extracted data. RESULTS: 35 studies provided data sufficient for meta-analysis. The quality of these observational studies was moderate to low with fair level of multivariable adjustments and adequate exposure and outcome ascertainment. Fasting hypertriglyceridemia was significantly associated with cardiovascular death (odds ratios (OR) 1.80; 95% confidence interval (CI) 1.31-2.49), cardiovascular events (OR, 1.37; 95% CI, 1.23-1.53), myocardial infarction (OR, 1.31; 95% CI, 1.15-1.49), and pancreatitis (OR, 3.96; 95% CI, 1.27-12.34, in one study only). The association with all-cause mortality was not statistically significant. CONCLUSIONS: The current evidence suggests that fasting hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.Précis: hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.
Authors: Min Jun; Celine Foote; Jicheng Lv; Bruce Neal; Anushka Patel; Stephen J Nicholls; Diederick E Grobbee; Alan Cass; John Chalmers; Vlado Perkovic Journal: Lancet Date: 2010-05-10 Impact factor: 79.321
Authors: Nicole Schupf; Rosann Costa; Jose Luchsinger; Ming-Xin Tang; Joseph H Lee; Richard Mayeux Journal: J Am Geriatr Soc Date: 2005-02 Impact factor: 5.562
Authors: Gunjan Y Gandhi; M Hassan Murad; Akira Fujiyoshi; Rebecca J Mullan; David N Flynn; Mohamed B Elamin; Brian A Swiglo; William L Isley; Gordon H Guyatt; Victor M Montori Journal: JAMA Date: 2008-06-04 Impact factor: 56.272
Authors: Robert C Block; Amir Abdolahi; Xin Tu; Steve N Georas; J Thomas Brenna; Richard P Phipps; Peter Lawrence; Shaker A Mousa Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2014-12-22 Impact factor: 4.006
Authors: Philip Allsopp; William Crowe; Bojlul Bahar; Pádraigín A Harnedy; Emma S Brown; Sonja S Taylor; Thomas J Smyth; Anna Soler-Vila; Pamela J Magee; Chris I R Gill; Conall R Strain; Vicky Hegan; Martin Devaney; Julie M W Wallace; Paul Cherry; Richard J FitzGerald; J J Strain; John V O'Doherty; Emeir M McSorley Journal: Eur J Nutr Date: 2015-08-08 Impact factor: 5.614
Authors: Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef Journal: J Clin Endocrinol Metab Date: 2012-09 Impact factor: 5.958
Authors: Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger Journal: Eur J Cancer Date: 2014-07-30 Impact factor: 9.162
Authors: Alexander Folwaczny; Elisa Waldmann; Julia Altenhofer; Kerstin Henze; Klaus G Parhofer Journal: Nutrients Date: 2021-05-20 Impact factor: 5.717